Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""MESH: Proto-Oncogene Proteins/metabolism"" wg kryterium: Temat


Wyświetlanie 1-13 z 13
Tytuł :
Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia
Autorzy :
Onorati, Marco
Li, Zhen
Liu, Fuchen
Sousa, André M. M.
Nakagawa, Naoki
Li, Mingfeng
Dell’Anno, Maria Teresa
Gulden, Forrest O.
Pochareddy, Sirisha
Tebbenkamp, Andrew T.N.
Han, Wenqi
Pletikos, Mihovil
Gao, Tianliuyun
Zhu, Ying
Bichsel, Candace
Varela, Luis
Szigeti-Buck, Klara
Lisgo, Steven
Zhang, Yalan
Testen, Anze
Gao, Xiao-Bing
Mlakar, Jernej
Popovic, Mara
Flamand, Marie
Strittmatter, Stephen M.
Kaczmarek, Leonard K.
Anton, E.S.
Horvath, Tamas L.
Lindenbach, Brett D.
Sestan, Nenad
Pokaż więcej
Temat :
MESH: Zika Virus/drug effects
MESH: Neural Stem Cells/ultrastructure
MESH: Neural Stem Cells/virology
MESH: Brain/embryology
MESH: Neuroprotective Agents/pharmacology
MESH: Receptor Protein-Tyrosine Kinases/metabolism
MESH: Neuroepithelial Cells/drug effects
MESH: Mitosis/drug effects
MESH: Neural Stem Cells/immunology
MESH: Neuroglia/virology
MESH: Transcription, Genetic/drug effects
MESH: Zika Virus/ultrastructure
MESH: Protein Kinase Inhibitors/pharmacology
MESH: Neuroepithelial Cells/immunology
MESH: Zika Virus Infection/virology
MESH: Microcephaly/pathology
[SDV]Life Sciences [q-bio]
MESH: Microcephaly/virology
MESH: Zika Virus/physiology
MESH: Neocortex/pathology
MESH: Neuroglia/pathology
MESH: Brain/virology
MESH: Neuroepithelial Cells/ultrastructure
MESH: Neural Stem Cells/enzymology
MESH: Immunity, Innate/drug effects
MESH: Neurons/pathology
MESH: Centrosome/metabolism
MESH: Fetus/virology
MESH: Nucleosides/pharmacology
MESH: Mitochondria/drug effects
MESH: Neurons/virology
MESH: Spinal Cord/pathology
MESH: Mitochondria/metabolism
MESH: Gene Expression Profiling
MESH: Proto-Oncogene Proteins/metabolism
MESH: Humans
MESH: Neuroepithelial Cells/virology
MESH: Cell Death/drug effects
MESH: Centrosome/drug effects
MESH: Phosphorylation/drug effects
MESH: Virus Replication/drug effects
MESH: Protein-Serine-Threonine Kinases/metabolism
QH301-705.5
MESH: Brain/pathology
MESH: Zika Virus/pathogenicity
MESH: Neurons/drug effects
[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology
MESH: Neuroglia/ultrastructure
MESH: Zika Virus Infection/pathology
Biology (General)
Źródło :
Cell Reports, Elsevier Inc, 2016, 16 (10), pp.2576-2592. ⟨10.1016/j.celrep.2016.08.038⟩
Cell Reports, Vol 16, Iss 10, Pp 2576-2592 (2016)
Tytuł :
TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis
Autorzy :
Mahfoudhi, Emna
Talhaoui, Ibtissam
Cabagnols, Xenia
Della Valle, Véronique
Secardin, Lise
Rameau, Philippe
Bernard, Olivier A
Ishchenko, Alexander A
Abbes, Salem
Vainchenker, William
Saparbaev, Murat
Plo, Isabelle
Pokaż więcej
Temat :
MESH: Animals
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
MESH: 5-Methylcytosine/metabolism
MESH: DNA-Binding Proteins/metabolism
MESH: Cytosine/metabolism
[SDV.BC] Life Sciences [q-bio]/Cellular Biology
[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]
TET2
MESH: Mutagenesis
MESH: Tumor Suppressor Protein p53/genetics
MESH: Genomic Instability
MESH: Megakaryocyte Progenitor Cells/cytology
MESH: Cell Line
MESH: 5-Methylcytosine/analogs & derivatives
MESH: Fibroblasts/cytology
MESH: B-Lymphocytes/cytology
MESH: DNA Repair
Genetic instability
MESH: Fibroblasts/metabolism
MESH: S Phase
MESH: Proto-Oncogene Proteins/metabolism
MESH: Megakaryocyte Progenitor Cells/metabolism
Cell cycle
5-hmC
MESH: Humans
MESH: Thymine DNA Glycosylase/genetics
MESH: Tumor Suppressor Protein p53/metabolism
MESH: Proto-Oncogene Proteins/genetics
MESH: Mice
MESH: Thymine DNA Glycosylase/deficiency
MESH: Epigenesis, Genetic
TDG
MESH: B-Lymphocytes/metabolism
MESH: Cytosine/analogs & derivatives
MESH: DNA-Binding Proteins/genetics
MESH: Base Sequence
MESH: Hydroxylation
Źródło :
DNA Repair, Elsevier, 2016, 43, pp.78 - 88. ⟨10.1016/j.dnarep.2016.05.031⟩
DNA Repair, Elsevier, 2016, 43, pp.78-88.
Tytuł :
6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.
Autorzy :
Amiable, Claire
Paoletti, Julie
Haouz, Ahmed
Padilla, André
Labesse, Gilles
Kaminski, Pierre-Alexandre
Pochet, Sylvie
Pokaż więcej
Temat :
MESH: Drug Design
MESH : Enzyme Inhibitors/pharmacology
MESH : Antineoplastic Agents/metabolism
MESH : Enzyme Inhibitors/metabolism
MESH : Antineoplastic Agents/pharmacology
MESH : Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Nuclear Proteins/metabolism
MESH : Animals
MESH : Nuclear Proteins/metabolism
MESH: Proto-Oncogene Proteins/chemistry
MESH: Nuclear Proteins/antagonists & inhibitors
MESH : Cell Line, Tumor
Inhibitor
[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology
MESH: Nuclear Proteins/chemistry
MESH : Protein Conformation
MESH : Antineoplastic Agents/chemical synthesis
MESH: Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Antineoplastic Agents/metabolism
MESH: N-Glycosyl Hydrolases/metabolism
MESH: Rats
MESH: Molecular Targeted Therapy
MESH : Molecular Docking Simulation
MESH : Proto-Oncogene Proteins/chemistry
MESH : Enzyme Inhibitors/chemical synthesis
MESH: N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: Purine Nucleotides/chemical synthesis
MESH: Chemistry Techniques, Synthetic
MESH : Chemistry Techniques, Synthetic
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
MESH : Humans
MESH: Antineoplastic Agents/chemistry
MESH: Purine Nucleotides/pharmacology
MESH : Drug Screening Assays, Antitumor
MESH : Purine Nucleotides/pharmacology
MESH: Cell Line, Tumor
MESH: Molecular Docking Simulation
MESH: Animals
MESH : Antineoplastic Agents/chemistry
MESH : Nuclear Proteins/chemistry
MESH: Purine Nucleotides/chemistry
MESH: Enzyme Inhibitors/chemistry
MESH : Enzyme Inhibitors/chemistry
MESH : Proto-Oncogene Proteins/metabolism
Nucleoside analogues
MESH : Purine Nucleotides/metabolism
MESH : Purine Nucleotides/chemistry
MESH: Enzyme Inhibitors/chemical synthesis
DNPH1
MESH: Enzyme Inhibitors/metabolism
MESH: Protein Conformation
MESH : Drug Design
MESH: Proto-Oncogene Proteins/metabolism
Cross-coupling reaction
MESH: Enzyme Inhibitors/pharmacology
MESH : Purine Nucleotides/chemical synthesis
MESH: Humans
MESH: Purine Nucleotides/metabolism
MESH: Antineoplastic Agents/pharmacology
MESH : Molecular Targeted Therapy
MESH : N-Glycosyl Hydrolases/chemistry
MESH: N-Glycosyl Hydrolases/chemistry
MESH : Rats
MESH : N-Glycosyl Hydrolases/metabolism
MESH: Antineoplastic Agents/chemical synthesis
MESH : N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: Drug Screening Assays, Antitumor
Crystal structure
Cancer
MESH: Structure-Activity Relationship
MESH : Nuclear Proteins/antagonists & inhibitors
MESH : Structure-Activity Relationship
Źródło :
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. ⟨10.1016/j.ejmech.2014.07.110⟩
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. 〈10.1016/j.ejmech.2014.07.110〉
European Journal of Medicinal Chemistry
Tytuł :
6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.
Autorzy :
Amiable, Claire
Paoletti, Julie
Haouz, Ahmed
Padilla, André
Labesse, Gilles
Kaminski, Pierre Alexandre
Pochet, Sylvie
Pokaż więcej
Temat :
Cancer
Cross-coupling reaction
Crystal structure
DNPH1
Inhibitor
Nucleoside analogues
MESH: Animals
MESH: Antineoplastic Agents/chemical synthesis
MESH: Enzyme Inhibitors/chemistry
MESH: Enzyme Inhibitors/metabolism
MESH: Enzyme Inhibitors/pharmacology
MESH: Humans
MESH: Molecular Docking Simulation
MESH: Molecular Targeted Therapy
MESH: N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: N-Glycosyl Hydrolases/chemistry
MESH: N-Glycosyl Hydrolases/metabolism
MESH: Nuclear Proteins/antagonists & inhibitors
MESH: Antineoplastic Agents/chemistry
MESH: Nuclear Proteins/chemistry
MESH: Nuclear Proteins/metabolism
MESH: Protein Conformation
MESH: Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Proto-Oncogene Proteins/chemistry
MESH: Proto-Oncogene Proteins/metabolism
MESH: Purine Nucleotides/chemical synthesis
MESH: Purine Nucleotides/chemistry
MESH: Purine Nucleotides/metabolism
MESH: Purine Nucleotides/pharmacology
MESH: Antineoplastic Agents/metabolism
MESH: Rats
MESH: Structure-Activity Relationship
MESH: Antineoplastic Agents/pharmacology
MESH: Cell Line, Tumor
MESH: Chemistry Techniques, Synthetic
MESH: Drug Design
MESH: Drug Screening Assays, Antitumor
MESH: Enzyme Inhibitors/chemical synthesis
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Źródło :
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. ⟨10.1016/j.ejmech.2014.07.110⟩
Tytuł :
6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.
Autorzy :
Amiable, Claire
Paoletti, Julie
Haouz, Ahmed
Padilla, André
Labesse, Gilles
Kaminski, Pierre Alexandre
Pochet, Sylvie
Pokaż więcej
Temat :
Cancer
Cross-coupling reaction
Crystal structure
DNPH1
Inhibitor
Nucleoside analogues
MESH: Animals
MESH: Antineoplastic Agents/chemical synthesis
MESH: Enzyme Inhibitors/chemistry
MESH: Enzyme Inhibitors/metabolism
MESH: Enzyme Inhibitors/pharmacology
MESH: Humans
MESH: Molecular Docking Simulation
MESH: Molecular Targeted Therapy
MESH: N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: N-Glycosyl Hydrolases/chemistry
MESH: N-Glycosyl Hydrolases/metabolism
MESH: Nuclear Proteins/antagonists & inhibitors
MESH: Antineoplastic Agents/chemistry
MESH: Nuclear Proteins/chemistry
MESH: Nuclear Proteins/metabolism
MESH: Protein Conformation
MESH: Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Proto-Oncogene Proteins/chemistry
MESH: Proto-Oncogene Proteins/metabolism
MESH: Purine Nucleotides/chemical synthesis
MESH: Purine Nucleotides/chemistry
MESH: Purine Nucleotides/metabolism
MESH: Purine Nucleotides/pharmacology
MESH: Antineoplastic Agents/metabolism
MESH: Rats
MESH: Structure-Activity Relationship
MESH: Antineoplastic Agents/pharmacology
MESH: Cell Line, Tumor
MESH: Chemistry Techniques, Synthetic
MESH: Drug Design
MESH: Drug Screening Assays, Antitumor
MESH: Enzyme Inhibitors/chemical synthesis
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Źródło :
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. ⟨10.1016/j.ejmech.2014.07.110⟩
Tytuł :
Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-{beta} pathways in Leydig cell lesions developed in male heterozygous multiple endocrine Neoplasia type 1 mutant mice
Autorzy :
Hussein, Nader
Lu, Jieli
Casse, Huguette
Fontanière, Sandra
Morera, Anne-Marie
Mazaud Guittot, Séverine
Calender, Alain
Di Clemente, Nathalie
Zhang, Chang
Pokaż więcej
Temat :
MESH: Animals
MESH: Anti-Mullerian Hormone/metabolism
MESH: Leydig Cell Tumor/metabolism
MESH: Leydig Cell Tumor/pathology
MESH: Luciferases/metabolism
MESH: Male
MESH: Mice
MESH: Mice, Knockout
MESH: Multiple Endocrine Neoplasia Type 1/metabolism
MESH: Multiple Endocrine Neoplasia Type 1/pathology
MESH: Plasmids
MESH: Proto-Oncogene Proteins/metabolism
MESH: Blotting, Northern
MESH: RNA, Messenger/genetics
MESH: RNA, Messenger/metabolism
MESH: Receptors, Peptide/metabolism
MESH: Receptors, Transforming Growth Factor beta/metabolism
MESH: Reverse Transcriptase Polymerase Chain Reaction
MESH: Smad Proteins/metabolism
MESH: Transforming Growth Factor beta/metabolism
MESH: Blotting, Western
MESH: Bone Morphogenetic Proteins/metabolism
MESH: Cyclin-Dependent Kinase Inhibitor p18/metabolism
MESH: Cyclin-Dependent Kinase Inhibitor p27/metabolism
MESH: Heterozygote
MESH: Immunoenzyme Techniques
MESH: Immunoprecipitation
[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
Źródło :
Endocrine-Related Cancer, BioScientifica, 2008, 15 (1), pp. 217-27. ⟨10.1677/ERC-06-0046⟩
Tytuł :
Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-{beta} pathways in Leydig cell lesions developed in male heterozygous multiple endocrine Neoplasia type 1 mutant mice
Autorzy :
Hussein, Nader
Lu, Jieli
Casse, Huguette
Fontanière, Sandra
Morera, Anne-Marie
Mazaud Guittot, Séverine
Calender, Alain
Di Clemente, Nathalie
Zhang, Chang
Pokaż więcej
Temat :
MESH: Animals
MESH: Anti-Mullerian Hormone/metabolism
MESH: Leydig Cell Tumor/metabolism
MESH: Leydig Cell Tumor/pathology
MESH: Luciferases/metabolism
MESH: Male
MESH: Mice
MESH: Mice, Knockout
MESH: Multiple Endocrine Neoplasia Type 1/metabolism
MESH: Multiple Endocrine Neoplasia Type 1/pathology
MESH: Plasmids
MESH: Proto-Oncogene Proteins/metabolism
MESH: Blotting, Northern
MESH: RNA, Messenger/genetics
MESH: RNA, Messenger/metabolism
MESH: Receptors, Peptide/metabolism
MESH: Receptors, Transforming Growth Factor beta/metabolism
MESH: Reverse Transcriptase Polymerase Chain Reaction
MESH: Smad Proteins/metabolism
MESH: Transforming Growth Factor beta/metabolism
MESH: Blotting, Western
MESH: Bone Morphogenetic Proteins/metabolism
MESH: Cyclin-Dependent Kinase Inhibitor p18/metabolism
MESH: Cyclin-Dependent Kinase Inhibitor p27/metabolism
MESH: Heterozygote
MESH: Immunoenzyme Techniques
MESH: Immunoprecipitation
[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
Źródło :
Endocrine-Related Cancer, BioScientifica, 2008, 15 (1), pp. 217-27. ⟨10.1677/ERC-06-0046⟩
Tytuł :
Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-{beta} pathways in Leydig cell lesions developed in male heterozygous multiple endocrine Neoplasia type 1 mutant mice
Autorzy :
Hussein, Nader
Lu, Jieli
Casse, Huguette
Fontanière, Sandra
Morera, Anne-Marie
Mazaud Guittot, Séverine
Calender, Alain
Di Clemente, Nathalie
Zhang, Chang
Pokaż więcej
Temat :
endocrine system
MESH: Animals
MESH: Male
MESH: Luciferases/metabolism
MESH: RNA, Messenger/genetics
MESH: RNA, Messenger/metabolism
MESH: Multiple Endocrine Neoplasia Type 1/metabolism
MESH: Leydig Cell Tumor/pathology
[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
MESH: Immunoprecipitation
endocrine system diseases
MESH: Blotting, Western
MESH: Plasmids
MESH: Bone Morphogenetic Proteins/metabolism
MESH: Leydig Cell Tumor/metabolism
MESH: Receptors, Transforming Growth Factor beta/metabolism
MESH: Proto-Oncogene Proteins/metabolism
MESH: Cyclin-Dependent Kinase Inhibitor p18/metabolism
congenital, hereditary, and neonatal diseases and abnormalities
MESH: Smad Proteins/metabolism
MESH: Blotting, Northern
MESH: Heterozygote
MESH: Immunoenzyme Techniques
MESH: Transforming Growth Factor beta/metabolism
MESH: Cyclin-Dependent Kinase Inhibitor p27/metabolism
MESH: Mice
MESH: Anti-Mullerian Hormone/metabolism
MESH: Reverse Transcriptase Polymerase Chain Reaction
MESH: Mice, Knockout
MESH: Receptors, Peptide/metabolism
MESH: Multiple Endocrine Neoplasia Type 1/pathology
Źródło :
Endocrine-Related Cancer, BioScientifica, 2008, 15 (1), pp. 217-27. ⟨10.1677/ERC-06-0046⟩
Tytuł :
Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-{beta} pathways in Leydig cell lesions developed in male heterozygous multiple endocrine Neoplasia type 1 mutant mice
Autorzy :
Hussein, Nader
Lu, Jieli
Casse, Huguette
Fontanière, Sandra
Morera, Anne-Marie
Mazaud Guittot, Séverine
Calender, Alain
Di Clemente, Nathalie
Zhang, Chang
Pokaż więcej
Temat :
MESH: Animals
MESH: Anti-Mullerian Hormone/metabolism
MESH: Leydig Cell Tumor/metabolism
MESH: Leydig Cell Tumor/pathology
MESH: Luciferases/metabolism
MESH: Male
MESH: Mice
MESH: Mice, Knockout
MESH: Multiple Endocrine Neoplasia Type 1/metabolism
MESH: Multiple Endocrine Neoplasia Type 1/pathology
MESH: Plasmids
MESH: Proto-Oncogene Proteins/metabolism
MESH: Blotting, Northern
MESH: RNA, Messenger/genetics
MESH: RNA, Messenger/metabolism
MESH: Receptors, Peptide/metabolism
MESH: Receptors, Transforming Growth Factor beta/metabolism
MESH: Reverse Transcriptase Polymerase Chain Reaction
MESH: Smad Proteins/metabolism
MESH: Transforming Growth Factor beta/metabolism
MESH: Blotting, Western
MESH: Bone Morphogenetic Proteins/metabolism
MESH: Cyclin-Dependent Kinase Inhibitor p18/metabolism
MESH: Cyclin-Dependent Kinase Inhibitor p27/metabolism
MESH: Heterozygote
MESH: Immunoenzyme Techniques
MESH: Immunoprecipitation
[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
Źródło :
Endocrine-Related Cancer, BioScientifica, 2008, 15 (1), pp. 217-27. ⟨10.1677/ERC-06-0046⟩
    Wyświetlanie 1-13 z 13

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies